• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305_MOSAIC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Congestive Heart Failure (1783); Non specific EKG/ECG Changes (1817); Unspecified Infection (1930); Myocardial Infarction (1969); Regurgitation (2259); Blood Loss (2597); Thromboembolism (2654)
Event Date 02/17/2016
Event Type  Injury  
Manufacturer Narrative
Citation: y.Okamoto et al."early and late outcomes of aortic valve replacement using bioprosthetic versus mechanical valve in elderly patients: a propensity analysis" doi: 10.1111/jocs.12719 (j card surg 2016;31:195¿202) earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding early and late outcomes of aortic valve replacement using bioprosthetic versus mechanical valve in elderly patients: a propensity analysis.All data were collected from a single center between (b)(6) 2014.The study population included 277 patients (predominantly female, mean age 80 years), 24 of which were implanted with medtronic ats mechanical valves and 36 were implanted with medtronic mosaic tissue valves (serial numbers not provided).Among all patients 14 deaths occurred.Multiple manufacturers were noted in the literature; based on the available information, none of the deaths were attributed to medtronic product.Among all patients adverse events included: cardiac arhythmias (atrioventricular block, ventricular fibrillation), re-operation for bleeding, stroke, infection, congestive heart failure, myocardial infarction, angina, minor paravalvular leak, thromboembolism.Based on the available information, these adverse events may have been attributed to medtronic product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6848633
MDR Text Key85134856
Report Number2025587-2017-01554
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 08/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305_MOSAIC
Device Catalogue Number305_MOSAIC
Was Device Available for Evaluation? No
Date Manufacturer Received08/17/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age80 YR
-
-